Attached files
| file | filename |
|---|---|
| 8-K - FORM 8-K - PROTO SCRIPT PHARMACEUTICAL CORP | pscr_8k.htm |
EXHIBIT 16.1
October 27, 2017
Securities and Exchange Commission
450 Fifth Street N.W.
Washington, DC 20549
We have read the statements of Proto Script Pharmaceutical Corp., pertaining to our firm included under Item 4.01 of Form 8-K dated October 25, 2017 and agree with such statements as they pertain to our firm.
Sincerely,
/s/ KLJ & Associates, LLP
5201 Eden Avenue
Suite 300
Edina MN 55436
630.277.2330